Home › Compare › PNAGF vs ABBV
PNAGF yields 4.42% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, PNAGF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PNAGF + ABBV for your $10,000?
PETRONAS Gas Berhad operates as a gas infrastructure and utilities company in Malaysia. The company engages in separating natural gas into components; and storing, transporting, distributing, and selling such components to industrial utilities. It operates through four segments: Gas Processing, Gas Transportation, Regasification, and Utilities. The Gas Processing segment processes natural gas from the gas fields of the East Coast of Peninsular Malaysia into sales gas and other by-products, such as ethane, propane, and butane. The Gas Transportation segment engages in the transportation of sales gas through its 2,623 kilometers of peninsular gas utilization pipeline network, as well as pengerang gas pipeline network. It also transports small volumes of sales gas through its gas distribution system in Miri and Bintulu, and Sarawak; exports sales gas to Singapore; and offers operation and maintenance services. The Regasification segment engages in the regasification of liquefied natural gas (LNG), as well as provides LNG reloading, truck loading, and gassing up and cooling down services. The Utilities segment manufactures, markets, and supplies industrial utilities to the petrochemical complexes in the Kertih and Gebeng Industrial Area. This segment offers electricity, steam, and industrial gases; and operations and maintenance services, as well as other utility products, such as oxygen, nitrogen, demineralized water, raw water, cooling water, and boiler feed water to petrochemical complexes and national electricity grid. The company was incorporated in 1983 and is based in Kuala Lumpur, Malaysia. PETRONAS Gas Berhad is a subsidiary of Petroliam Nasional Berhad.
Full PNAGF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.